11, 2024 GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death in adults who had an initial stroke, according to a preliminary study to be presented at the American Heart Associations Scientific Sessions 2024
Highlights GLP-1 medicines reduce fat and liver mass more rapidly than skeletal muscle (SKM) Running performance is maintained or improved in mice on GLP-1 medicine GLP-1 medicine modifies the SKM proteome despite similar weight loss as calorie restriction Patients on GLP-1 medicine slightly reduce SKM mass but largely maintain strength Summary The large decrease in body weight with glucagon-like peptide-1 (GLP-1) medicines raises concern about a loss of lean body mass (LBM) and skeletal muscle
That's why we focused on the goals of improving patient experiences via the preferred oral delivery method whilst preserving the efficacy of the underlying medication
People who have a problem with swallowing the capsules, can pull the capsule apart and dissolve the powder in water
The article uses the contrast between rows to argue that individual health status matters more than chronological age on its own
People couldn't access the brand-name weight-loss drugs like Ozempic and Mounjaro because high demand triggered shortages